Share Price and Basic Stock Data
Last Updated: October 14, 2025, 11:26 pm
| PEG Ratio | 6.76 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
COSYN Ltd, operating in the IT Consulting and Software industry, reported a market capitalization of ₹18.1 Cr with a share price of ₹24.2. The company’s revenue from operations has shown fluctuations over the past quarters, with sales recorded at ₹2.98 Cr in June 2022, escalating to ₹5.16 Cr in September 2022, before declining to ₹3.11 Cr in June 2023. The most recent quarter, September 2023, saw sales rise again to ₹4.20 Cr. For the fiscal year ending March 2025, total revenue stood at ₹14.81 Cr, down from ₹14.84 Cr in March 2023, indicating a plateau in growth. The trailing twelve-month (TTM) revenue was reported at ₹12.09 Cr, suggesting a declining trend compared to earlier fiscal periods. The company’s operational performance is under scrutiny as the cash conversion cycle stretched to an alarming 2,528.39 days, indicating potential inefficiencies in managing receivables and inventory. Overall, while there are segments of revenue recovery, the overall trend depicts a challenging environment for COSYN Ltd.
Profitability and Efficiency Metrics
COSYN Ltd’s profitability metrics reflect a mixed performance. The operating profit margin (OPM) stood at a robust 46.48% in June 2025, showcasing the company’s ability to maintain operational efficiency despite fluctuating sales. However, this is juxtaposed with a troubling trend of negative net profits in several quarters, particularly a loss of ₹1.14 Cr in June 2023, with a subsequent recovery to a net profit of ₹0.36 Cr in September 2023. For the fiscal year ending March 2025, the net profit recorded was ₹0.16 Cr, a decline from ₹0.30 Cr in March 2023. The return on equity (ROE) was reported at 5.63%, while the return on capital employed (ROCE) was significantly lower at 3.13%. These figures suggest that while COSYN Ltd has managed to achieve high margins in certain quarters, the overall profitability remains under pressure, raising concerns about sustainable growth and efficiency in capital utilization.
Balance Sheet Strength and Financial Ratios
The balance sheet of COSYN Ltd indicates a relatively stable financial position, with total reserves amounting to ₹22.26 Cr against borrowings of ₹2.05 Cr, resulting in a low debt-to-equity ratio of 0.00. This suggests a conservative capital structure with minimal reliance on debt financing, providing a buffer against economic uncertainties. The interest coverage ratio (ICR) stood at 3.57x, indicating that the company can comfortably cover its interest obligations. However, liquidity ratios depict a mixed picture; the current ratio is at 2.75, which is generally considered healthy, while the quick ratio at 2.25 also reflects adequate liquidity. Nevertheless, the cash conversion cycle of 2,528.39 days raises concerns about the efficiency of working capital management. Overall, while COSYN Ltd maintains a strong reserve position and low debt levels, the effectiveness of its asset management warrants attention.
Shareholding Pattern and Investor Confidence
COSYN Ltd’s shareholding pattern shows a dominant promoter holding of 54.46%, indicating a strong commitment from the management. However, foreign institutional investors (FIIs) have no reported stake, and domestic institutional investors (DIIs) hold none, which may reflect a lack of confidence from institutional players. The public shareholding stood at 45.55%, with a total of 4,880 shareholders as of June 2025. Notably, the number of shareholders has fluctuated, with a high of 4,901 in June 2024, suggesting a degree of volatility in retail investor interest. The absence of institutional investment could be a red flag for potential investors, indicating that confidence in the company’s future performance may not be robust. As investor sentiment plays a crucial role in stock performance, the reliance on a concentrated promoter stake could pose risks if operational performance does not improve significantly.
Outlook, Risks, and Final Insight
If COSYN Ltd can sustain its recovery in sales and improve its profitability metrics, particularly by addressing its cash conversion cycle issues, it may enhance shareholder confidence and attract institutional investment. However, the company faces significant risks, including the potential for ongoing volatility in its revenue streams and the challenge of converting high operational margins into net profits consistently. Additionally, with a high operating profit margin juxtaposed against declining net profits, the company must focus on efficient cost management and enhancing revenue predictability. Should COSYN Ltd successfully navigate these challenges and demonstrate a consistent growth trajectory, it may position itself favorably within the IT consulting sector, ultimately driving investor interest and market capitalization growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of COSYN Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.39/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 27.9 Cr. | 8.82 | 10.2/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 179 Cr. | 166 | 194/99.8 | 39.9 | 33.2 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 36.5 Cr. | 285 | 310/140 | 28.3 | 19.0 | 0.35 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.49 Cr. | 1.34 | 1.73/0.91 | 59.0 | 2.52 | 0.00 % | 2.14 % | 2.15 % | 2.00 |
| Industry Average | 18,967.97 Cr | 560.81 | 143.00 | 118.21 | 0.53% | 14.92% | 20.95% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.98 | 5.16 | 3.29 | 3.65 | 3.11 | 4.20 | 3.39 | 4.80 | 3.43 | 3.29 | 3.31 | 4.78 | 0.71 |
| Expenses | 2.64 | 4.73 | 3.01 | 3.40 | 4.09 | 3.66 | 3.19 | 3.65 | 3.21 | 3.08 | 3.05 | 6.30 | 0.38 |
| Operating Profit | 0.34 | 0.43 | 0.28 | 0.25 | -0.98 | 0.54 | 0.20 | 1.15 | 0.22 | 0.21 | 0.26 | -1.52 | 0.33 |
| OPM % | 11.41% | 8.33% | 8.51% | 6.85% | -31.51% | 12.86% | 5.90% | 23.96% | 6.41% | 6.38% | 7.85% | -31.80% | 46.48% |
| Other Income | 0.05 | 0.05 | 0.05 | 0.08 | 0.06 | 0.07 | 0.07 | 0.03 | 0.02 | 0.01 | 0.01 | 2.13 | 0.04 |
| Interest | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.06 | 0.04 | 0.06 | 0.07 | 0.06 | 0.17 | 0.12 |
| Depreciation | 0.23 | 0.24 | 0.24 | 0.25 | 0.19 | 0.19 | 0.20 | 0.20 | 0.13 | 0.13 | 0.14 | 0.16 | 0.20 |
| Profit before tax | 0.14 | 0.22 | 0.07 | 0.06 | -1.13 | 0.37 | 0.01 | 0.94 | 0.05 | 0.02 | 0.07 | 0.28 | 0.05 |
| Tax % | 35.71% | 27.27% | 42.86% | 83.33% | 0.88% | 2.70% | 100.00% | 13.83% | 20.00% | 50.00% | 28.57% | 75.00% | 20.00% |
| Net Profit | 0.09 | 0.16 | 0.04 | 0.01 | -1.14 | 0.36 | 0.00 | 0.82 | 0.04 | 0.01 | 0.04 | 0.07 | 0.04 |
| EPS in Rs | 0.12 | 0.21 | 0.05 | 0.01 | -1.52 | 0.48 | 0.00 | 1.09 | 0.05 | 0.01 | 0.05 | 0.09 | 0.05 |
Last Updated: August 19, 2025, 8:40 pm
Below is a detailed analysis of the quarterly data for COSYN Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 4.78 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 4.07 Cr..
- For Expenses, as of Jun 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.30 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 5.92 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from -1.52 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 1.85 Cr..
- For OPM %, as of Jun 2025, the value is 46.48%. The value appears strong and on an upward trend. It has increased from -31.80% (Mar 2025) to 46.48%, marking an increase of 78.28%.
- For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.13 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.09 Cr..
- For Interest, as of Jun 2025, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.17 Cr. (Mar 2025) to 0.12 Cr., marking a decrease of 0.05 Cr..
- For Depreciation, as of Jun 2025, the value is 0.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.28 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.23 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 75.00% (Mar 2025) to 20.00%, marking a decrease of 55.00%.
- For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.07 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 0.03 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.05. The value appears to be declining and may need further review. It has decreased from 0.09 (Mar 2025) to 0.05, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.50 | 22.08 | 27.71 | 31.47 | 42.70 | 39.57 | 29.90 | 19.89 | 13.41 | 14.84 | 13.73 | 14.38 | 12.09 |
| Expenses | 10.07 | 19.29 | 23.08 | 23.87 | 31.63 | 33.06 | 24.63 | 17.49 | 14.22 | 13.45 | 12.55 | 14.92 | 12.81 |
| Operating Profit | 2.43 | 2.79 | 4.63 | 7.60 | 11.07 | 6.51 | 5.27 | 2.40 | -0.81 | 1.39 | 1.18 | -0.54 | -0.72 |
| OPM % | 19.44% | 12.64% | 16.71% | 24.15% | 25.93% | 16.45% | 17.63% | 12.07% | -6.04% | 9.37% | 8.59% | -3.76% | -5.96% |
| Other Income | 0.04 | 0.07 | 0.21 | 0.24 | 0.32 | 0.43 | 0.28 | 0.29 | 2.76 | 0.23 | 0.23 | 2.18 | 2.19 |
| Interest | 0.42 | 0.42 | 0.45 | 0.28 | 1.71 | 1.81 | 0.54 | 0.23 | 0.08 | 0.17 | 0.44 | 0.66 | 0.42 |
| Depreciation | 0.80 | 0.97 | 0.75 | 0.85 | 0.94 | 1.76 | 2.64 | 2.38 | 1.71 | 0.96 | 0.77 | 0.56 | 0.63 |
| Profit before tax | 1.25 | 1.47 | 3.64 | 6.71 | 8.74 | 3.37 | 2.37 | 0.08 | 0.16 | 0.49 | 0.20 | 0.42 | 0.42 |
| Tax % | 34.40% | -46.26% | -2.20% | 2.09% | 18.76% | 30.56% | 20.68% | 25.00% | 62.50% | 38.78% | 75.00% | 59.52% | |
| Net Profit | 0.82 | 2.14 | 3.71 | 6.57 | 7.09 | 2.34 | 1.88 | 0.06 | 0.07 | 0.30 | 0.04 | 0.16 | 0.16 |
| EPS in Rs | 1.10 | 2.85 | 4.95 | 8.76 | 9.45 | 3.12 | 2.51 | 0.08 | 0.09 | 0.40 | 0.05 | 0.21 | 0.20 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 11.42% | 10.58% | 16.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 160.98% | 73.36% | 77.09% | 7.91% | -67.00% | -19.66% | -96.81% | 16.67% | 328.57% | -86.67% | 300.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -87.61% | 3.72% | -69.17% | -74.91% | 47.34% | -77.15% | 113.48% | 311.90% | -415.24% | 386.67% |
COSYN Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -13% |
| 3 Years: | 3% |
| TTM: | -24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -23% |
| 5 Years: | -39% |
| 3 Years: | 32% |
| TTM: | -87% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 9% |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: October 10, 2025, 3:49 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.42 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 | 7.50 |
| Reserves | 3.85 | 4.43 | 8.15 | 14.20 | 20.39 | 22.22 | 21.68 | 21.69 | 21.76 | 22.06 | 22.10 | 22.26 |
| Borrowings | 2.28 | 2.55 | 2.39 | 0.85 | 4.42 | 3.56 | 1.39 | 0.33 | 0.66 | 0.49 | 1.79 | 2.05 |
| Other Liabilities | 9.30 | 9.39 | 9.88 | 11.67 | 7.03 | 10.26 | 12.81 | 7.30 | 6.74 | 6.75 | 6.19 | 7.91 |
| Total Liabilities | 22.85 | 23.87 | 27.92 | 34.22 | 39.34 | 43.54 | 43.38 | 36.82 | 36.66 | 36.80 | 37.58 | 39.72 |
| Fixed Assets | 4.89 | 2.78 | 3.40 | 3.43 | 3.59 | 7.66 | 6.24 | 4.86 | 6.65 | 6.25 | 5.68 | 3.79 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.31 | 0.00 | 0.61 | 1.17 | 1.18 | 1.58 | 2.38 | 2.23 |
| Investments | 0.00 | 0.00 | 0.01 | 1.84 | 2.20 | 2.28 | 2.31 | 2.34 | 2.38 | 2.42 | 2.42 | 2.42 |
| Other Assets | 17.96 | 21.09 | 24.51 | 28.95 | 32.24 | 33.60 | 34.22 | 28.45 | 26.45 | 26.55 | 27.10 | 31.28 |
| Total Assets | 22.85 | 23.87 | 27.92 | 34.22 | 39.34 | 43.54 | 43.38 | 36.82 | 36.66 | 36.80 | 37.58 | 39.72 |
Below is a detailed analysis of the balance sheet data for COSYN Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.50 Cr..
- For Reserves, as of Mar 2025, the value is 22.26 Cr.. The value appears strong and on an upward trend. It has increased from 22.10 Cr. (Mar 2024) to 22.26 Cr., marking an increase of 0.16 Cr..
- For Borrowings, as of Mar 2025, the value is 2.05 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.79 Cr. (Mar 2024) to 2.05 Cr., marking an increase of 0.26 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.19 Cr. (Mar 2024) to 7.91 Cr., marking an increase of 1.72 Cr..
- For Total Liabilities, as of Mar 2025, the value is 39.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 37.58 Cr. (Mar 2024) to 39.72 Cr., marking an increase of 2.14 Cr..
- For Fixed Assets, as of Mar 2025, the value is 3.79 Cr.. The value appears to be declining and may need further review. It has decreased from 5.68 Cr. (Mar 2024) to 3.79 Cr., marking a decrease of 1.89 Cr..
- For CWIP, as of Mar 2025, the value is 2.23 Cr.. The value appears to be declining and may need further review. It has decreased from 2.38 Cr. (Mar 2024) to 2.23 Cr., marking a decrease of 0.15 Cr..
- For Investments, as of Mar 2025, the value is 2.42 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.42 Cr..
- For Other Assets, as of Mar 2025, the value is 31.28 Cr.. The value appears strong and on an upward trend. It has increased from 27.10 Cr. (Mar 2024) to 31.28 Cr., marking an increase of 4.18 Cr..
- For Total Assets, as of Mar 2025, the value is 39.72 Cr.. The value appears strong and on an upward trend. It has increased from 37.58 Cr. (Mar 2024) to 39.72 Cr., marking an increase of 2.14 Cr..
Notably, the Reserves (22.26 Cr.) exceed the Borrowings (2.05 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.15 | 0.24 | 2.24 | 6.75 | 6.65 | 2.95 | 3.88 | 2.07 | -1.47 | 0.90 | -0.61 | -2.59 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116.80 | 118.36 | 170.58 | 198.10 | 84.97 | 188.27 | 209.60 | 244.98 | 340.23 | 267.11 | 332.04 | 347.99 |
| Inventory Days | 804.21 | 316.12 | 34.44 | 2,377.30 | ||||||||
| Days Payable | 714.85 | 606.16 | 118.98 | 196.91 | ||||||||
| Cash Conversion Cycle | 116.80 | 118.36 | 259.94 | -91.94 | 84.97 | 103.72 | 209.60 | 244.98 | 340.23 | 267.11 | 332.04 | 2,528.39 |
| Working Capital Days | 95.78 | 79.02 | 109.20 | 110.76 | 80.61 | 95.01 | 117.56 | 200.76 | 290.97 | 248.91 | 323.53 | 287.37 |
| ROCE % | 13.44% | 13.49% | 25.15% | 34.44% | 38.10% | 15.80% | 9.27% | 1.03% | 0.81% | 2.20% | 2.08% | 2.62% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.21 | 0.05 | 0.33 | -0.20 | -0.54 |
| Diluted EPS (Rs.) | 0.21 | 0.05 | 0.33 | -0.20 | -0.54 |
| Cash EPS (Rs.) | 0.96 | 1.08 | 1.63 | 2.33 | 3.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.56 | 36.35 | 36.38 | 36.05 | 36.26 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.56 | 36.35 | 36.38 | 36.05 | 36.26 |
| Revenue From Operations / Share (Rs.) | 19.74 | 20.67 | 20.10 | 17.93 | 26.53 |
| PBDIT / Share (Rs.) | 1.81 | 1.52 | 2.00 | 2.50 | 3.45 |
| PBIT / Share (Rs.) | 1.06 | 0.48 | 0.69 | -0.04 | -0.30 |
| PBT / Share (Rs.) | 0.54 | 0.25 | 0.58 | -0.08 | -0.53 |
| Net Profit / Share (Rs.) | 0.21 | 0.04 | 0.32 | -0.21 | -0.56 |
| NP After MI And SOA / Share (Rs.) | 0.21 | 0.04 | 0.32 | -0.20 | -0.53 |
| PBDIT Margin (%) | 9.17 | 7.34 | 9.93 | 13.96 | 12.99 |
| PBIT Margin (%) | 5.35 | 2.32 | 3.45 | -0.22 | -1.16 |
| PBT Margin (%) | 2.78 | 1.21 | 2.88 | -0.48 | -2.01 |
| Net Profit Margin (%) | 1.07 | 0.22 | 1.63 | -1.17 | -2.11 |
| NP After MI And SOA Margin (%) | 1.07 | 0.22 | 1.63 | -1.12 | -2.02 |
| Return on Networth / Equity (%) | 0.58 | 0.12 | 0.90 | -0.56 | -1.48 |
| Return on Capital Employeed (%) | 2.87 | 1.31 | 1.88 | -0.10 | -0.84 |
| Return On Assets (%) | 0.42 | 0.09 | 0.71 | -0.43 | -1.15 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 0.40 | 0.44 | 0.42 | 0.37 | 0.50 |
| Current Ratio (X) | 2.75 | 2.87 | 3.22 | 3.26 | 3.28 |
| Quick Ratio (X) | 2.25 | 2.23 | 2.69 | 2.81 | 2.85 |
| Inventory Turnover Ratio (X) | 0.13 | 0.15 | 0.19 | 0.19 | 0.19 |
| Interest Coverage Ratio (X) | 3.57 | 6.60 | 17.71 | 53.52 | 15.24 |
| Interest Coverage Ratio (Post Tax) (X) | 1.42 | 1.20 | 3.91 | -3.49 | -1.48 |
| Enterprise Value (Cr.) | 10.24 | 23.94 | 8.25 | 11.51 | 8.95 |
| EV / Net Operating Revenue (X) | 0.69 | 1.54 | 0.54 | 0.85 | 0.44 |
| EV / EBITDA (X) | 7.54 | 21.03 | 5.50 | 6.13 | 3.46 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.70 | 0.88 | 1.17 | 0.75 |
| Price / BV (X) | 0.57 | 0.96 | 0.48 | 0.58 | 0.55 |
| Price / Net Operating Revenue (X) | 1.06 | 1.70 | 0.88 | 1.17 | 0.75 |
| EarningsYield | 0.01 | 0.00 | 0.01 | -0.01 | -0.02 |
After reviewing the key financial ratios for COSYN Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.21, marking an increase of 0.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.21, marking an increase of 0.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 3. It has decreased from 1.08 (Mar 24) to 0.96, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.56. It has increased from 36.35 (Mar 24) to 36.56, marking an increase of 0.21.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.56. It has increased from 36.35 (Mar 24) to 36.56, marking an increase of 0.21.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.74. It has decreased from 20.67 (Mar 24) to 19.74, marking a decrease of 0.93.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 2. It has increased from 1.52 (Mar 24) to 1.81, marking an increase of 0.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 0.48 (Mar 24) to 1.06, marking an increase of 0.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.25 (Mar 24) to 0.54, marking an increase of 0.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.21, marking an increase of 0.17.
- For PBDIT Margin (%), as of Mar 25, the value is 9.17. This value is below the healthy minimum of 10. It has increased from 7.34 (Mar 24) to 9.17, marking an increase of 1.83.
- For PBIT Margin (%), as of Mar 25, the value is 5.35. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 24) to 5.35, marking an increase of 3.03.
- For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from 1.21 (Mar 24) to 2.78, marking an increase of 1.57.
- For Net Profit Margin (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.22 (Mar 24) to 1.07, marking an increase of 0.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 8. It has increased from 0.22 (Mar 24) to 1.07, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 15. It has increased from 0.12 (Mar 24) to 0.58, marking an increase of 0.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has increased from 1.31 (Mar 24) to 2.87, marking an increase of 1.56.
- For Return On Assets (%), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.42, marking an increase of 0.33.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.44 (Mar 24) to 0.40, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 2.87 (Mar 24) to 2.75, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 2. It has increased from 2.23 (Mar 24) to 2.25, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 4. It has decreased from 0.15 (Mar 24) to 0.13, marking a decrease of 0.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.57. This value is within the healthy range. It has decreased from 6.60 (Mar 24) to 3.57, marking a decrease of 3.03.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 3. It has increased from 1.20 (Mar 24) to 1.42, marking an increase of 0.22.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10.24. It has decreased from 23.94 (Mar 24) to 10.24, marking a decrease of 13.70.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 1.54 (Mar 24) to 0.69, marking a decrease of 0.85.
- For EV / EBITDA (X), as of Mar 25, the value is 7.54. This value is within the healthy range. It has decreased from 21.03 (Mar 24) to 7.54, marking a decrease of 13.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.06, marking a decrease of 0.64.
- For Price / BV (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.57, marking a decrease of 0.39.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.70 (Mar 24) to 1.06, marking a decrease of 0.64.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in COSYN Ltd:
- Net Profit Margin: 1.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.87% (Industry Average ROCE: 14.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.58% (Industry Average ROE: 20.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.25
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 117 (Industry average Stock P/E: 143)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 3rd Floor, TP House, D.No 1 98/9/J/15, Plot No 15(P), Hyderabad Telangana 500081 | comsec@cosyn.in http://www.cosyn.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Vishnu | Managing Director |
| Mr. Bhopal Reddy | Executive Director |
| Mrs. Ravi Kasturi | Non Executive Woman Director |
| Mr. Rama Rao Karumanchi | Independent Director |
| Mr. Panduranga Murthy Vistakula | Independent Director |
| Mr. Chennaiah Athota | Independent Director |
FAQ
What is the intrinsic value of COSYN Ltd?
COSYN Ltd's intrinsic value (as of 15 October 2025) is 213.39 which is 756.99% higher the current market price of 24.90, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹18.7 Cr. market cap, FY2025-2026 high/low of 61.7/20.4, reserves of ₹22.26 Cr, and liabilities of 39.72 Cr.
What is the Market Cap of COSYN Ltd?
The Market Cap of COSYN Ltd is 18.7 Cr..
What is the current Stock Price of COSYN Ltd as on 15 October 2025?
The current stock price of COSYN Ltd as on 15 October 2025 is 24.9.
What is the High / Low of COSYN Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of COSYN Ltd stocks is 61.7/20.4.
What is the Stock P/E of COSYN Ltd?
The Stock P/E of COSYN Ltd is 117.
What is the Book Value of COSYN Ltd?
The Book Value of COSYN Ltd is 39.7.
What is the Dividend Yield of COSYN Ltd?
The Dividend Yield of COSYN Ltd is 0.00 %.
What is the ROCE of COSYN Ltd?
The ROCE of COSYN Ltd is 3.13 %.
What is the ROE of COSYN Ltd?
The ROE of COSYN Ltd is 5.63 %.
What is the Face Value of COSYN Ltd?
The Face Value of COSYN Ltd is 10.0.